You are viewing: UK Pharmaceutical Quality Management Software (QMS) Market analysis

The UK Pharmaceutical Quality Management Software (QMS) Market was valued at $94 Million in 2025 and projected to reach to $179.5 Million by 2030, representing a compound annual growth rate of 13.8%. The UK Pharmaceutical Quality Management Software market is positioned for sustained expansion through 2030, driven by intensifying regulatory scrutiny from MHRA and the need for manufacturers to demonstrate compliance with evolving quality standards.

UK Pharmaceutical Quality Management Software (QMS) Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Pharmaceutical Quality Management Software (QMS) Market Trends and Insights

  • The UK market is driven by stringent regulatory compliance requirements from the MHRA and EMA, increasing digitalization of pharmaceutical manufacturing processes, and the UK's commitment to maintaining high quality standards post-Brexit.
  • The UK's advanced healthcare infrastructure and strong pharmaceutical manufacturing base position it as a key market for QMS adoption across the forecast period. The UK pharmaceutical sector's emphasis on operational excellence and risk management is accelerating QMS software implementation across small, medium, and large enterprises.
  • The UK market benefits from early technology adoption, skilled IT workforces, and significant investment in life sciences innovation hubs.
  • With a 13.8% compound annual growth rate, the UK QMS market is outpacing global growth trends, reflecting the region's regulatory complexity and competitive pharmaceutical landscape.
  • By 2030, the UK is expected to solidify its position as a leading European market for quality management solutions..

Key Market Statistics

  • CAGR (2025-2030) 13.8% CAGR
  • Market Size, 2025 ~USD 94 Million
  • Forecast, 2030 ~USD 179.5 Million
  • Country UK

UK Pharmaceutical Quality Management Software (QMS) Market Overview

MHRA & EMA Compliance Drivers :

UK pharmaceutical manufacturers face stringent regulatory requirements from the Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA), driving adoption of advanced QMS solutions to ensure continuous compliance and audit readiness.

Manufacturing Digitalization Wave :

UK pharma facilities are accelerating digital transformation initiatives, with QMS software becoming essential for automating quality processes, reducing manual documentation, and improving operational efficiency across manufacturing sites.

Post-Brexit Quality Standards :

Following Brexit, the UK has reinforced its commitment to maintaining world-class pharmaceutical quality standards, with QMS adoption becoming critical for UK manufacturers to demonstrate compliance with independent MHRA regulations and international market access.

Strong Market Growth Trajectory :

The UK market is valued at $94.0 million in 2025 and projected to reach $179.5 million by 2030, representing a robust 13.8% CAGR, outpacing the global average of 13.3% and reflecting strong regional demand.

UK Pharmaceutical Quality Management Software (QMS) Market Dynamics

  • UK pharma companies are increasingly investing in cloud-based QMS platforms to streamline batch record management, deviation tracking, and supplier quality management, while also addressing post-Brexit operational complexities. The market will be further supported by the UK's life sciences strategy and growing emphasis on advanced manufacturing technologies.
  • Investment in Industry 4.0 capabilities, coupled with rising costs of non-compliance and product recalls, will accelerate QMS adoption among mid-sized and large pharmaceutical manufacturers.
  • Emerging opportunities in contract manufacturing organizations (CMOs) and specialty pharma sectors will contribute to market diversification and sustained growth momentum..

Related Ecosystem

Healthcare Analytics

Top Technologies
  • Machine Learning
  • Natural Language Processing (NLP)
  • Blood Pressure Monitors
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
Top Companies
  • Oracle Corporation
  • PHILIPS HEALTHCARE
  • Siemens healthineers
  • Zensar Technologies Limited
  • International Business Machines Corporation

    Healthcare It

    Top Technologies
    • Computed Tomography (CT)
    • Machine Learning
    • Magnetic Resonance Imaging (MRI)
    • Natural Language Processing (NLP)
    • Predictive Analytics
    Top Companies
    • CERNER CORPORATION
    • PHILIPS HEALTHCARE
    • Oracle Corporation
    • GE HealthCare Technologies Inc.
    • Siemens healthineers

      Key Takeaways

      • The UK Pharmaceutical QMS market is valued at $94.0 million in 2025 and will nearly double to $179.5 million by 2030, representing a 13.8% CAGR.
      • The UK's post-Brexit regulatory environment and MHRA compliance requirements are primary drivers of QMS software adoption across the UK pharmaceutical sector.
      • The UK market is outpacing global growth trends due to advanced manufacturing infrastructure, early technology adoption, and strong life sciences investment.
      • By 2030, the UK is positioned as a leading European QMS market, driven by digital transformation initiatives and quality-centric operational strategies.

      Pharmaceutical Quality Management Software (QMS) Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment BIOTECHNOLOGY COMPANIES (End User)
      Forecast Period 2025–2030
      Growth Rate CAGR of 13.3% from 2025 to 2030
      Largest Segment LARGE ENTERPRISES (Enterprise Size)
      Market Size Base Year (Billions) ~USD 1.6 (2025)
      Revenue Forecast (Billions) ~USD 2.98 (2030)
      Segments Covered Process, Application, Enterprise Size, End User, End User 2023–2030

      UK Pharmaceutical Quality Management Software (QMS) Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Process

      • Clinical Trials
      • Commercialization, Marketing, & Sales
      • Commercialization, Marketing, And Sales
      • Distribution & Supply Chain
      • Manufacturing/ Production
      • Other Processes
      • Post-Market Surveillance
      • Quality Assurance/ Quality Control
      • Quality Assurance/Quality Control
      • Regulatory Compliance

      By Application

      • Audit & Inspection Management
      • Capa (Corrective & Preventive Action) Management
      • Change Control Management
      • Document Control & Esop
      • Other Applications
      • Regulatory & Compliance Management
      • Risk Management
      • Supplier Quality Management
      • Training Management

      By Enterprise Size

      • Large Enterprises
      • Small & Medium Enterprises

      By End User

      • Biotechnology Companies
      • Contract Development & Manufacturing Organizations (Cdmo)
      • Contract Development And Manufacturing Organization (Cdmo)
      • Contract Development And Manufacturing Organization (Cdmos)
      • Contract Development And Manufacturing Organizations (Cdmo)
      • Contract Research Organization (Cro)
      • Contract Research Organizations (Cro)
      • Contract Research Organizations (Cros)
      • Other End Users
      • Pharmaceutical Companies

      By End User 2023–2030

      • Biotechnology Companies
      • Contract Development And Manufacturing Organizations (Cdmo)
      • Contract Research Organizations (Cro)
      • Other End Users
      • Pharmaceutical Companies

      UK: PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      BIOTECHNOLOGY COMPANIES16.618.921.624.628.132.236.942.414.5
      CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMO)11.112.514.115.91820.423.126.313.3
      CONTRACT RESEARCH ORGANIZATIONS (CRO)11.913.415.217.219.422.125.128.613.5
      OTHER END USERS4.555.56.26.97.78.69.711.8
      PHARMACEUTICAL COMPANIES29.233.137.642.748.655.563.472.614.1
      TOTAL73.58394106.6121.1137.9157.2179.513.8

      Target Audience

      • UK Pharmaceutical Manufacturers : Large and mid-sized pharma companies operating in the UK need detailed market insights to evaluate QMS investments, understand competitive offerings, and ensure MHRA compliance while optimizing manufacturing quality processes.
      • Contract Manufacturing Organizations (CMOs) : UK-based CMOs require market intelligence to benchmark QMS capabilities against competitors, justify technology investments to clients, and demonstrate quality management excellence to maintain regulatory standing and customer confidence.
      • QMS Software Vendors & Technology Providers : Software companies and IT solution providers targeting the UK pharma sector need market data to identify growth opportunities, understand customer pain points, and develop region-specific product strategies aligned with MHRA requirements.
      • Regulatory & Quality Consultants : Compliance consultants and quality assurance firms serving UK pharmaceutical clients require market insights to advise on QMS selection, regulatory trends, and best practices while supporting clients' digital transformation initiatives.
      • Private Equity & Investment Firms : Investors evaluating pharma sector opportunities in the UK need comprehensive market analysis to assess QMS market attractiveness, identify acquisition targets, and understand growth drivers for portfolio company valuations.

      Key Companies in the UK Pharmaceutical Quality Management Software (QMS) Market

      CompanyHQOwnershipStrongest segments
      HONEYWELL INTERNATIONAL INC.United StatesPublic CompanyIndustrial Automation (control, instrumentation, smart energy, sensing, PPE, software and analytics),Building Automation (building control software, energy management, security, fire, services),Energy and Sustainability Solutions / UOP (licensed process technologies, equipment, catalysts, software),
      IQVIAUnited StatesPublic CompanyTechnology & Analytics Solutions,Research & Development Solutions,Contract Sales & Medical Solutions,
      VEEVA SYSTEMS INC.United StatesPublic CompanyVeeva Commercial Cloud (Vault CRM, Medical, PromoMats, Crossix, CRM Pulse),Veeva Development Cloud (Clinical Platform, Clinical Data Management, Safety, RIM),Veeva Quality Cloud,
      DASSAULT SYSTèMESFrancePublic Company3D Modeling (CATIA, SOLIDWORKS, GEOVIA, BIOVIA),PLM & Collaboration (ENOVIA, CENTRIC PLM, 3DEXCITE, 3DEXPERIENCE platform),Simulation & Manufacturing (SIMULIA, DELMIA, 3DVIA),
      HEXAGON ABSwedenPublic CompanyManufacturing Intelligence (metrology, CAD/CAM, CAE, quality software),Geosystems (surveying, mapping, laser scanning, AEC solutions),Autonomous Solutions and Positioning (GNSS, anti-jam, machine control, autonomy),
      IDEAGENUnited KingdomPrivate CompanyRegulatory Compliance & GRC Platforms,Operational Performance & Quality Management,Workplace Health & Safety (incl. Reactec),
      SOFTEXPERTBrazilPrivate CompanyBusiness Process & Corporate Performance Management,Enterprise Quality, Risk & GRC,Enterprise Content & Asset Management,
      INSTEMUnited KingdomPrivate CompanyResearch study management software (discovery, preclinical, early clinical),Regulatory submission solutions (SEND generation, conversion, validation),In silico and data insights solutions,
      INTELLECT, INCIndiaPublic CompanyWholesale & Corporate Banking (lending, payments, liquidity, trade, treasury),Consumer Banking (core, lending, cards, digital engagement),Wealth, Capital Markets, and Insurance Platforms,

      HONEYWELL INTERNATIONAL INC.

      Honeywell International Inc. is a diversified technology and manufacturing company founded in 1885 and headquartered in the United States. With 101,000 employees, the publicly traded company operates across multiple industrial sectors including aerospace, building technologies, and performance materials.

      IQVIA

      IQVIA is a United States-based public company with 93,000 employees that provides integrated information and technology solutions to the life sciences industry.

      VEEVA SYSTEMS INC.

      Veeva Systems Inc. is a United States public company founded in 2007 with 7,928 employees that provides cloud-based software solutions for the life sciences industry.

      DASSAULT SYSTèMES

      Dassault Systèmes is a French public company founded in 1981 with 25,724 employees that provides 3D design, digital mock-up, and product lifecycle management software solutions.

      HEXAGON AB

      Hexagon AB is a Swedish public company founded in 1975 with 16,118 employees that provides digital solutions and software for industrial and geospatial applications.

      IDEAGEN

      Ideagen is a United Kingdom-based private company founded in 1993 with 697 employees that develops software solutions for quality, risk, and compliance management.

      SOFTEXPERT

      SoftExpert is a Brazil-based private company founded in 1995 with 170 employees that provides software solutions for process management, quality, and compliance.

      INSTEM

      Instem is a United Kingdom-based private company founded in 1969 with 510 employees that provides software and services for the life sciences and pharmaceutical industries.

      INTELLECT, INC

      Intellect, Inc. is an India-based public company founded in 2011 with 6,876 employees that provides software and IT solutions for various industries.

      Reasons to Buy this Report

      • Regulatory Compliance Intelligence : Gain deep insights into MHRA and EMA regulatory requirements specific to UK pharmaceutical operations, enabling informed investment decisions in QMS solutions that ensure continuous compliance and reduce audit risk.
      • Market Sizing & Growth Projections : Access precise UK market valuation ($94M in 2025, $179.5M by 2030) and segment breakdowns to identify high-growth opportunities and benchmark competitive positioning within the regional market landscape.
      • Post-Brexit Opportunity Assessment : Understand how post-Brexit regulatory independence is reshaping UK pharma QMS requirements and creating differentiated market dynamics compared to EU markets, enabling targeted go-to-market strategies.
      • Competitive Landscape Analysis : Identify key UK market players, emerging vendors, and technology trends driving QMS adoption among manufacturers, CMOs, and specialty pharma companies to inform partnership and acquisition strategies.
      • Investment & Expansion Planning : Leverage UK-specific market data to support business case development, capital allocation decisions, and expansion planning for QMS vendors, consultants, and technology providers targeting the pharmaceutical sector.

      Frequently asked questions

      What is the current size of the UK Pharmaceutical QMS market?

      The UK Pharmaceutical QMS market is valued at $94.0 million in 2025 and is projected to reach $179.5 million by 2030.

      What is the growth rate of the UK QMS market?

      The UK Pharmaceutical QMS market is growing at a compound annual growth rate (CAGR) of 13.8% from 2025 to 2030.

      What are the main drivers of QMS adoption in the UK?

      Key drivers include MHRA and EMA regulatory compliance requirements, post-Brexit quality standards, digital transformation initiatives, and the UK's advanced pharmaceutical manufacturing infrastructure.

      How does the UK market compare to global QMS market growth?

      The UK market is growing at 13.8% CAGR, which outpaces the global pharmaceutical QMS market growth rate of 13.3%, reflecting the UK's regulatory complexity and competitive landscape.

      Which sectors in the UK are driving QMS software demand?

      The UK pharmaceutical manufacturing, contract manufacturing organizations (CMOs), and life sciences sectors are primary drivers of QMS software adoption due to stringent quality and compliance requirements.

      RESEARCH METHODOLOGY

      The study involved several key activities to estimate the current size of the pharmaceutical quality management software (QMS) market. Extensive secondary research was conducted to gather information on this market. The next step was to validate the findings, assumptions, and size estimates by consulting industry experts throughout the value chain through primary research. We employed various methods, including top-down and bottom-up approaches, to estimate the overall market size. Following this, we utilized market segmentation and data triangulation techniques to determine the size of specific segments and subsegments within the pharmaceutical quality management softwarecare market.

      Secondary Research

      This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for companies providing pharmaceutical quality management software care solutions is assessed using secondary data from both paid and free sources. This involves analysing the product portfolios of major players in the industry and evaluating these companies based on their performance and quality. Various resources were utilized in the secondary research process to gather information for this study. The sources include annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, directories, and databases.

      Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the pharmaceutical quality management software market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

      Primary research was conducted to identify segmentation types; industry trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.

      After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyse industry trends, evaluate the competitive landscape of pharmaceutical quality management software care offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

      In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

      Pharmaceutical Quality Management Software Market
 Size, and Share

      Others include sales managers, marketing managers, and product managers.

      Note: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by process, application, enterprise size, end users, and region).

      Pharmaceutical Quality Management Software Market: Top-Down and Bottom-Up Approach

      Pharmaceutical Quality Management Software Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the overall market size, using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the pharmaceutical quality management software market.

      Market Definition

      Pharmaceutical quality management software is a formalized, electronic system designed to document, automate, and manage all processes, procedures, and responsibilities associated with ensuring the quality and regulatory compliance of pharmaceutical products throughout their lifecycle. It serves as a centralized platform for managing critical quality activities including document control, SOPs, CAPA, audits, training, risk management, and supplier quality to ensure product safety, efficacy, and regulatory compliance..

      Key Stakeholders

      • Pharmaceutical companies
      • Pharmaceutical quality management software Providers
      • Biotechnology firms
      • Academic Research Institutes
      • Contract Manufacturing Organizations
      • Contract Research Organizations
      • Market Research and Consulting Firms
      • Regulatory Authorities / Agencies
      • Quality Assurance & Quality Control Departments
      • Research & Development (R&D) Teams
      • Third-party Auditors / Inspections Bodies
      • Suppliers / Raw Material Vendors

      Report Objectives

      • To define, describe, and forecast the global pharmaceutical quality management software market based on process, application, enterprise size, end users, and region.
      • To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall pharmaceutical quality management software market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the pharmaceutical quality management software market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
      • To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the pharmaceutical quality management software market
      • To benchmark players within the pharmaceutical quality management software market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      Company Information

      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe Pharmaceutical quality management software Market into Denmark, Norway, and others
      • Further breakdown of the Rest of Asia Pacific Pharmaceutical quality management software Market into Vietnam, Pakistan, New Zealand, and others
      • Further breakdown of the Rest of Latin America Pharmaceutical quality management software Market into Argentina, Chile, Colombia, and others
      • Further breakdown of the Rest of Middle East & Africa Pharmaceutical quality management software Market into Egypt, Nigeria, Israel, and others

      Get the Full Pharmaceutical Quality Management Software (QMS) Market Report

      Full forecast, segment splits, and company analysis for all Pharmaceutical Quality Management Software (QMS) Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status